These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule. Abe M, Tasaki K, Tominaga K, Fukuhara S, Imai S, Osato T, Wakasa H. Cancer; 1992 Feb 01; 69(3):763-71. PubMed ID: 1309680 [Abstract] [Full Text] [Related]
4. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Walter J, Möller P, Moldenhauer G, Schirrmacher V, Pawlita M, Wolf J. Int J Cancer; 1992 Jan 21; 50(2):265-73. PubMed ID: 1309726 [Abstract] [Full Text] [Related]
5. Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1. Joshi SS, DeBoer JM, Strandjord SJ, Pirruccello SJ, Sanger WG, Weisenburger DD, Sharp JG. Int J Cancer; 1991 Mar 12; 47(5):643-8. PubMed ID: 1848532 [Abstract] [Full Text] [Related]
7. Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines. Surface markers, growth characteristics, cytogenetics, and transplantability. Abe M, Nozawa Y, Wakasa H, Ohno H, Fukuhara S. Cancer; 1988 Feb 01; 61(3):483-90. PubMed ID: 3338018 [Abstract] [Full Text] [Related]
8. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient. Roncella S, Di Celle PF, Cutrona G, Carbone A, Sessarego M, Landonio G, Foà R, Rowe M, Ferrarini M. Leuk Lymphoma; 1993 Jan 01; 9(1-2):157-64. PubMed ID: 8386576 [Abstract] [Full Text] [Related]
9. Human herpesvirus 6 (HHV-6)-positive Burkitt's lymphoma: establishment of a novel cell line infected with HHV-6. Bandobashi K, Daibata M, Kamioka M, Tanaka Y, Kubonishi I, Taguchi H, Ohtsuki Y, Miyoshi I. Blood; 1997 Aug 01; 90(3):1200-7. PubMed ID: 9242553 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus and Burkitt's lymphoma. Magrath I, Jain V, Bhatia K. Semin Cancer Biol; 1992 Oct 01; 3(5):285-95. PubMed ID: 1335792 [Abstract] [Full Text] [Related]
11. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion. Thielen C, Herens C, Fassotte MF, Detrooz E, Drion P, Diss T, Boniver J, de Leval L. Eur J Haematol; 2006 Oct 01; 77(4):318-26. PubMed ID: 16856916 [Abstract] [Full Text] [Related]
12. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J, Pawlita M, Bullerdiek J, zur Hausen H. Cancer Res; 1990 May 15; 50(10):3095-100. PubMed ID: 2159373 [Abstract] [Full Text] [Related]
13. Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3)(p11;q27) from a liver transplant patient. Yoshizawa K, Kiyosawa K, Yamada S, Furuta K, Yabu K, Kitano K, Akamatsu T, Nakayama J, Katsuyama T, Matsunami H. Cancer Genet Cytogenet; 1993 Dec 15; 71(2):155-63. PubMed ID: 7506636 [Abstract] [Full Text] [Related]
14. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines. Perez-Chacon G, de Los Rios C, Zapata JM. Pharmacol Res; 2014 Nov 15; 89():46-56. PubMed ID: 25180456 [Abstract] [Full Text] [Related]
15. Spontaneous development of a chromosomal translocation 5;14 in an Epstein-Barr-virus-associated B-cell lymphoma in a SCID mouse. Glaser R, Theil KS, Bonneau RH, Sheridan JF, Vasquez M, Allen CM. Int J Cancer; 1993 Sep 09; 55(2):281-7. PubMed ID: 8396561 [Abstract] [Full Text] [Related]
16. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes. Daibata M, Taguchi T, Nemoto Y, Iwasaki S, Ohtsuki Y, Taguchi H. Int J Cancer; 2006 Jan 15; 118(2):513-7. PubMed ID: 16049984 [Abstract] [Full Text] [Related]
17. A case of Japanese Burkitt's lymphoma associated with EB virus. Shikano T, Ueno N, Matsumoto T, Ohkawa M, Tono-Oka T, Okano M, Yano S, Osato T. Jpn J Clin Oncol; 1984 Sep 15; 14(3):445-50. PubMed ID: 6090736 [Abstract] [Full Text] [Related]
18. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. Gaidano G, Parsa NZ, Tassi V, Della-Latta P, Chaganti RS, Knowles DM, Dalla-Favera R. Leukemia; 1993 Oct 15; 7(10):1621-9. PubMed ID: 8412324 [Abstract] [Full Text] [Related]
19. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation. Cohen JH, Revillard JP, Magaud JP, Lenoir G, Vuillaume M, Manel AM, Vincent C, Bryon PA. J Natl Cancer Inst; 1987 Feb 15; 78(2):235-42. PubMed ID: 3027441 [Abstract] [Full Text] [Related]
20. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Okano M, Kikuta H, Abo W, Koizumi S, Aya T, Yano S, Takada K, Mizuno F, Osato T. Jpn J Clin Oncol; 1992 Oct 15; 22(5):320-4. PubMed ID: 1281896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]